Mondaq Asia Pacific: Food, Drugs, Healthcare, Life Sciences
Sparke Helmore Lawyers
In situations where there are questions around consent to treatment, health care providers may obtain court guidance.
Jones Day
How the Opinions would be implemented is unclear and remains to be seen.
Ropes & Gray LLP
Unlike the DRR, the Revisions do not distinguish an international multicenter study from a drug registration study.
Ropes & Gray LLP
Ask a senior manager of a MedTech company in China what keeps her or him awake at night and "regulatory changes" will invariably be among the first things mentioned.
Foley & Lardner
These developments present significant opportunities for foreign health care providers and other investors.
Ropes & Gray LLP
The China Food and Drug Administration ("CFDA") recently proposed a draft circular to address the priority review designation issue for medical devices, namely the Circular Regarding Soliciting Comments Regarding Priority Review Designation Procedure for Medical Devices (CFDA Circular [2016] No.40, the "Circular").
Jones Day
Some pioneering industrial players have already made movements in this regard.
Ropes & Gray LLP
China's State Council announced on May 26, 2016, a detailed pilot plan for the Marketing Authorization Holder System ("MAH") for drugs in 10 provinces in China.
Ropes & Gray LLP
On March 23, 2016, the China Food and Drug Administration ("CFDA") and the National Health and Family Planning Commission jointly promulgated the final revision to the 2004 Medical Device Clinical Studies Rules...
King & Wood Mallesons
We have analyzed drug policies with regard to drug pricing and the centralized procurement of drugs in the previous Key 2015 Healthcare and Pharmaceutical Policies: Pharmaceuticals.
Khaitan & Co
The Hon'ble Supreme Court of India has, in the case of State of Uttar Pradesh v Dr Dinesh Singh Chauhan, struck down the practice of grant of reservation for in-service candidates in post graduate medical degree courses.
Singh & Associates
The regulatory framework relating to clinical trial of drugs is governed under the Drugs and Cosmetics Act, 1940 ("Act") and the Drugs and Cosmetics Rules, 1945.
Singh & Associates
In an information release by Press Information Bureau on 14th May 2016, Ministry of AYUSH Government of India and the World Health organization (WHO) have signed an historic Project Collaboration Agreement (PCA) for cooperation on promoting the quality, safety and effectiveness of service provision in traditional and complementary medicine.
Nishith Desai Associates
TPG Growth has acquired a significant majority stake in Bengaluru based Rhea Healthcare Pvt. Ltd. as its recent investment in healthcare space in India.
Deloitte
In 2014 we published a report on End of Life Care in the UK and subsequently have written a number of related blogs on this important subject.
TMT Law Practice
""If I said tennis is totally clean, I would be kidding myself [..] I would say there are certainly some short cuts being taken. Not that many, but it would be crazy to think differently." - Nick Bollettieri
PSA Legal Counsellors
This move not only makes clinical trials for academic research on drugs more cost effective and efficient, but also promotes innovation in terms of treatment of critical maladies like AIDS, cancer, etc.
Khaitan & Co
The Competition Appellate Tribunal (COMPAT) on 10 May 2016 has passed a landmark decision setting aside the Competition Commission of India's (CCI) decision in P K Krishnan v Paul Madavana and Ors.
Nishith Desai Associates
A Roundtable on Cloud Computing – Privacy, Security & Legal Compliance Considerations in the Digital Transformation of Healthcare in India, Part 3 (Apr 26, 2016).
LawQuest
It is a well-known fact that India is at par with US, Europe and Australia when it comes to medical treatment and facilities but is considerably less expensive.
Most Popular Recent Articles
HSA Advocates
GSK had planned to challenge these generic versions of paroxetine as the generic drugs would have infringed GSK's patents.
Singh & Associates
The report highlighted for the need for a central legislation for registration of clinical establishments in the country and uniform standards need to be developed for the entire country.
Norton Rose Fulbright Australia
Food offered for retail sale will be required to be labelled more clearly to inform consumers of the product's origins.
HBA Legal
An Information Standard has been created which sets out the new country of origin labelling for food sold in Australia.
Singh & Associates
In an information release by Press Information Bureau on 14th May 2016, Ministry of AYUSH Government of India and the World Health organization (WHO) have signed an historic Project Collaboration Agreement (PCA) for cooperation on promoting the quality, safety and effectiveness of service provision in traditional and complementary medicine.
Ropes & Gray LLP
Unlike the DRR, the Revisions do not distinguish an international multicenter study from a drug registration study.
Shelston IP
For a patent to be eligible for a term extension, the pharmaceutical substance must be explicitly listed on the ARTG.
Stacks Law Firm
It's a great defect in our law that the Compensation to Relatives Act doesn't have any provision for bereavement damages.
Legalmax
This articles addresses issues related to the protection of the rights of brand-name drug patent holders in connection with generic drugs registration by other manufacturers.
Singh & Associates
The Indian Patent Office on April 1, 2016 denied Cipla (Applicant) limited a patent for its HIV drug comprising "ritonavir" and "darunavir" involving the patent application 1399/MUMNP/2010 entitled, "Antiretroviral Combination".
Article Search Using Filters
Related Topics
Mondaq Advice Centre (MACs)
Popular Authors
Popular Contributors
Up-coming Events Search
Tools
Font Size:
Translation
Channels
Mondaq on Twitter